d-gam human anti-d immunoglobulin
bio products laboratory limited - anti, d immunoglobulin, human - solution for injection - anti-d immunoglobulin, human 250 international unit(s)/millilitre - immune sera and immunoglobulins
rhophylac 1500iu human anti-d immunoglobulin solution for injection syringe
csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 1500 iu - injection, solution - excipient ingredients: chloride; glycine; sodium; albumin - prevention of rh sensitisation in rh(d)-negative females at or below child-bearing age and treatment of rh(d)-negative persons after incompatible transfusions of rh(d)-positive blood or other products containing red blood cells.
csl hepatitis b immunoglobulin vf (human) 100iu injection vial
csl behring australia pty ltd - human immunoglobulin g, quantity: 160 mg/ml; hepatitis b immunoglobulin, quantity: 100 iu - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - indications as at 8 august 2002 : hepatitis b immunoglobulin is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete, or when the hepatitis b antibody level is inadequate (<10iu/l). post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to hbsag-positive material or suspected hbsag-positive material, for example, by needle stick, oral ingestion or sexual exposure. hepatitis b immunoglobulin is also indicated for prophylaxis in infants born to hbsag-positive mothers. hepatitis b immunoglobulin-vf is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete, or when the hepatitis b antibody level is inadequate (<10iu/l). post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to hbsag-positive or suspected hbsag-positive material, for example, by needle stick, oral ingestion or sexual exposure. hepatitis b immunoglobulin-vf is also indicated for prophylaxis in infants born to hbsag-positive mothers.
csl rh(d) immunoglobulin vf (human) 250 iu injection vial
csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 250 iu; anti-d rho immunoglobulin, quantity: 10 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - rh(d) immunoglobulin is indicated for the prevention of rh sensitisation in rh(d)negative females at or below child bearing age.
csl rh(d) immunoglobulin vf (human) 625iu injection vial
csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 625 iu; anti-d rho immunoglobulin, quantity: 30 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - indications as at 6 august 2002 : rh(d) immunoglobulin is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.
rhesonativ 625 iu/ml, solution for injection
octapharma (ip) limited - anti-d immunoglobulin, human - solution for injection - anti-d immunoglobulin, human 625 iu/ml - immune sera and immunoglobulins
rhesonativ solution for injection 625iu/ml (1ml amp)
octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - anti, d immunoglobulin, human - solution for injection - anti-d immunoglobulin, human 625 iu/ml - immune sera and immunoglobulins
rhesonativ solution for injection 625iu/ml (2ml amp)
octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - anti, d immunoglobulin, human - solution for injection - anti-d immunoglobulin, human 625 iu/ml - immune sera and immunoglobulins
d-gam 50 micrograms/ml solution for injection
bpl bioproducts laboratory gmbh dornhofstraße 34, 63263 neu-isenburg,, germany - anti, d immunoglobulin, human - solution for injection - anti-d immunoglobulin, human 250 iu/ml - immune sera and immunoglobulins
csl hepatitis b immunoglobulin vf (human) 400iu injection vial
csl behring australia pty ltd - hepatitis b immunoglobulin, quantity: 400 iu; human immunoglobulin g, quantity: 160 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - hepatitis b immunoglobulin-vf is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete, or when the hepatitis b antibody level is inadequate (<10iu/l). post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to hbsag-positive or suspected hbsag-positive material, for example, by needle stick, oral ingestion or sexual exposure. hepatitis b immunoglobulin-vf is also indicated for prophylaxis in infants born to hbsag-positive mothers.